MedPath

The use of a natural medicine, S-adenolsylmethionine (SAM-e) in the treatment of Fibromyalgia and Chronic Fatigue Syndrome

Recruiting
Conditions
Fibromyalgia
Musculoskeletal - Other muscular and skeletal disorders
Chronic Fatigue Syndrome
Registration Number
ACTRN12607000377437
Lead Sponsor
Deakin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Diagnosis of Fibromyalgia by a medical practitioner.Diagnosis of Chronic Fatigue Syndrome by a medical practitioner.

Exclusion Criteria

Pregnancy, Concurrent manic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom reduction in both Fibromyalgia and Chronic Fatigue Syndrome. Specifically we expect a reduction in depressive symptoms, sleep disturbances and gastric disturbances.[Measured at four points in time: pre-trial and at 8, 16 and 24 weeks.]
Secondary Outcome Measures
NameTimeMethod
Examination of dose-response data and the nature of the placebo effect in these conditions.[Measured at four points in time: pre-trial and at 8, 16 and 24 weeks.]
© Copyright 2025. All Rights Reserved by MedPath